Prognostic significance of allelic losses in primary melanoma

Oncogene

Volumn 16, Issue 17, 1998, Pages 2213-2218

  Healy, Eugene ^a   Belgaid, Christine ^a   Takata, Minoru ^a,c   Harrison, David ^a   Zhu, Ning Wen ^b   Burd, D Andrew R ^b   Rigby, Howard S ^b   Matthews, John N S ^a   Rees, Jonathan L ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

Fractional allelic loss; Loss of heterozygosity; p21(WAF1); p53; Proliferation; Tumour suppressor gene

Indexed keywords

KI 67 ANTIGEN; PROTEIN P21; PROTEIN P53;

ALLELE; ARTICLE; CANCER SURVIVAL; CHROMOSOME 10Q; CHROMOSOME 6Q; CHROMOSOME 9P; CHROMOSOME ARM; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL;

EID: 0032580365     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200203     Document Type: Article

References (70)

1. Albino AP, Vidal MJ, McNutt NS, Shea CR, Prieto VG, Nanus DM, Palmer JM and Hayward NK. (1994). Melanoma Res., 4, 35-45.
2. Allred DC, Clark GM, Elledge R, Fuqua SAW, Brown RW, Chamness GC, Osborne CK and McGuire WL. (1993). J. Natl. Cancer. Inst., 85, 200-206.
3. Barth A, Wanek LA and Morton DL. (1995). J. Am. Coll. Surg., 181, 193-201.
4. Breslow A. (1970). Annals. Surg., 172, 902-908.
5. Boni R, Doguoglu A, Burg G, Muller B and Dummer R. (1996). J. Am. Acad. Dermatol., 35, 416-418.
6. Bouzubar N, Walker KJ, Griffiths K, Ellis IO, Elston CW, Robertson JFR, Blarney RW and Nicholson RI. (1989). Br. J. Cancer, 59, 943-947.
7. Castresana JS, Rubio MP, Vazquez JJ, Idoate M, Sober AJ, Seizinger BR and Barnhill RL. (1993). Int. J. Cancer, 55, 562-565.
8. Collett D. (ed). (1994). Modelling survival data in medical research. Chapman & Hall: London.
9. Cowan JM, Halaban R and Francke U. (1988). J. Natl. Cancer Inst., 80, 1159-1164.
10. Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE and Kefford RF. (1989). Proc. Natl. Acad. Sci. USA, 86, 4614-4618.
11. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
12. El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW and Vogelstein B. (1995). Cancer Res., 55, 2910-2919.
13. Field JK, Kiaris H, Risk JM, Tsiriyotis C, Adamson R, Zoumpourlis V, Rowley H, Taylor K, Whittaker J, Howard P, Beirne JC, Gosney JR, Woolgar J, Vaughan ED, Spandidos DA and Jones AS. (1995). Br. J. Cancer, 72, 1180-1188.
14. Florenes VA, Oyjord T, Holm R, Skrede M, Borresen AL, Nesland JM and Fodstad O. (1994). Br. J. Cancer, 69, 253-259.
15. Flores JF, Walker GJ, Glendening JM, Haluska FG, Castresana JS, Rubio MP, Pastorfide GC, Boyer LA, Kap WH, Bulyk ML, Barnhill RL, Hayward NK, Housman DE and Fountain JW. (1996). Cancer Res., 56, 5023-5032.
16. Fountain JW, Karayiorgou M, Ernstoff MS, Kirkwood JM, Vlock DR, Titus-Ernstoff L, Bouchard B, Vijayasaradhi S, Houghton AN, Lahti J, et al. (1992). Proc. Natl. Acad. Sci. USA, 89, 10557-10561.
17. Furihata M, Inoue K, Ohtsuki Y, Hashimoto H, Terao N and Fujita Y. (1993). Cancer Res., 53, 4823-4827.
18. Gabra H, Watson JEV, Taylor KJ, Mackay J, Leonard RCF, Steel CM, Porteous DJ and Smyth JF. (1996). Cancer Res., 56, 950-954.
19. Gruis NA, van der Velden PA, Sandkuijl LA, Prins DE, Weaver-Feldhaus J, Kamb A, Bergman W and Frants RR. (1995a). Nature Genet., 10, 351-353.
20. Gruis NA, Weaver-Feldhaus J, Liu Q, Frye C, Eeles R, Orlow I, Lacombe L, Ponce-Castaneda V, Lianes P, Latres E, Skolnick MH, Cordon-Cardo C and Kamb A. (1995b). Am. J. Pathol., 146, 1199-1206.
21. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. (1993). Cell, 75, 805-816.
22. Healy E, Rehman I, Angus B and Rees JL. (1995). Genes Chromosom. Cancer, 12, 152-156.
23. Healy E, Belgaid CE, Takata M, Vahlquist A, Rehman I, Rigby H and Rees JL. (1996a). Cancer Res., 56, 589-593.
24. Healy E, Sikkink S and Rees JL. (1996b). J. Invest. Dermatol., 107, 318-321.
25. Heaton KM, Rippon MB, El-Naggar A, Tucker SL, Ross MI and Balch CM. (1993). Am. J. Surg., 166, 648-653.
26. Herbst RA, Weiss J, Ehnis A, Cavenee WK and Arden KC. (1994). Cancer Res., 54, 3111-3114.
27. Holland EA, Beaton SC, Edwards BG, Kefford RF and Mann GJ. (1994). Oncogene, 9, 1361-1365.
28. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH, Jr, Tucker MA and Dracopoli NC. (1994). Nature Genet., 8, 15-21.
29. Ishida T, Kaneko S, Akazawa K, Tateishi M, Sugio K and Sugimachi K. (1993). Cancer Res., 53, 5000-5003.
30. Isshiki K, Elder DE, Guerry D and Linnenbach AJ. (1993). Genes Chromosom Cancer, 8, 178-184.
31. Isshiki K, Seng BA, Elder DE, Guerry D and Linnenbach AJ. (1994). Oncogene, 9, 1649-1653.
32. Jackson DP, Hayden JD and Quirke P. (1992). PCR, a practical approach. McPhearson MJ, Quirke P and Taylor GR (eds.). Oxford University Press: Oxford, pp. 29-50.
33. Jen J, Kim H, Piantadosi S, Liu ZF, Levitt RC, Sistonen P, Kinzler KW, Vogelstein B and Hamilton SR. (1994). N. Eng. J. Med., 331, 213-221.
34. Jiang H and Fisher PB. (1993). Mol. Cell. Differentiation, 1, 285-299.
35. Jiang H, Lin J, Su ZZ, Herlyn M, Kerbel RS, Weissman BE, Welch DR and Fisher PB. (1995). Oncogene, 10, 1855-1864.
36. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, McClure M, Aitken JF, Anderson DE, Bergman W, Frants R, Goldgar DE, Green A, MacLennan R, Martin NG, Meyer LJ, Youl P, Zone JJ, Skolnick MH and Cannon-Albright LA. (1994). Nature Genet., 8, 22-26.
37. Kim SK, Ro JY, Kemp BL, Lee JS, Kwon TJ, Fong KM, Sekido Y, Minna JD, Hong WK and Mao L. (1997). Cancer Res., 57, 400-403.
38. Lee SM, Betticher DC and Thatcher N. (1995). Br. Med. Bull., 51, 609-630.
39. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R. (1997). Science, 275, 1943-1947.
40. Lubbe J, Reichel M, Burg G and Kleihues P. (1994). J. Invest. Dermatol., 102, 819-821.
41. Maeda K, Chung YS, Onoda N, Kato Y, Nitta A, Arimoto Y, Yamada N, Kondo Y and Sowa M. (1994). Cancer, 73, 528-533.
42. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D. (1995). Nature Med., 1, 686-692.
43. Millikin D, Meese E, Vogelstein B, Witkowski C and Trent J. (1991). Cancer Res., 51, 5449-5453.
44. Montano X, Shamsher M, Whitehead P, Dawson K and Newton J. (1994). Oncogene, 9, 1455-1459.
45. Morton DL, Davtyan DG, Wanek LA, Foshag LJ and Cochran AJ. (1993). Cancer, 71, 3737-3743.
46. Muhonen T, Pyrhonen S, Laasonen A, Wasenius VM, Asko-Seljavaara S, Franssila K and Kangas L. (1992). Br. J. Cancer, 66, 528-532.
47. Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh AD, Shields JA, Shields CL, Croce CM and Huebner K. (1994). Cancer Res., 54, 5269-5272.
48. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockel KH and Becher R (1996). Lancet, 347, 1222-1225.
49. Puig S, Ruiz A, Lazaro C, Castel T, Lynch M, Palou J, Vilalta A, Weissenbach J, Mascaro JM and Estivill X. (1995). Am. J. Hum. Genet., 57, 395-402.
50. Quelle DE, Zindy F, Ashmun RA and Sherr CJ. (1995). Cell, 83, 993-1000
51. Quinlan DC, Davidson AG, Summers CL, Warden HE and Doshi HM. (1992). Cancer Res., 52, 4828-4831.
52. Ramsay JA, From L, Iscoe NA and Kahn HJ. (1995). J. Invest. Dermatol., 105, 22-26.
53. Ray ME, Wistow G, Su YA, Meltzer PS and Trent JM. (1997). Proc. Natl. Acad. Sci. USA, 94, 3229-3234.
54. Rees JL and Healy E. (1996). Clin. Exp. Dermatol., 21, 253-262.
55. Roses DF, Harris MN, Rigel D, Carrey Z, Friedman R and Kopf AW. (1983). Ann. Surg., 198, 65-69.
56. Scheistroen M, Trope C, Koern J, Pettersen EO, Abeler VM and Kristensen GB. (1995). Cancer, 75, 72-80.
57. STATA Corporation. (1997). STATA statistical software. Release 5.0. STATA Corporation: Texas.
58. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF and Tavtigian SV. (1997). Nature Genet., 15, 356-362.
59. Stretch JR, Gatter KC, Ralfkiaer E, Lane DP and Harris AL. (1991). Cancer Res., 51, 5976-5979.
60. Sun XF, Carstensen JM, Zhang H, Stal O, Wingren S, Hatschek T and Nordenskjold B. (1992). Lancet, 340, 1369-1373.
61. Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN and Jenkins RB. (1995). Cancer Res., 55, 4114-4119.
62. Thompson FH, Emerson J, Olson S, Weinstein R, Leavitt SA, Leong SPL, Emerson S, Trent JM, Nelson MA, Salmon SE and Taetle R. (1995). Cancer Genet. Cytogenet., 83, 93-104.
63. Trent JM, Meyskens FL, Salmon SE, Ryschon K, Leong SP, Davis JR and McGee DL. (1990). N. Engl. J. Med., 322, 1508-1511.
64. Umebayashi Y and Otsuka F. (1995). Arch. Dermatol. Res., 287, 718-722.
65. Valverde P, Healy E, Sikkink S, Haldane F, Thody AJ, Carothers A, Jackson U and Rees JL. (1996). Hum. Mol. Genet., 5, 1663-1666.
66. Vidal MJ, Loganzo F, Jr, de Oliveira AR, Hayward NK and Albino AP. (1995). Melanoma Res., 5, 243-250.
67. Walker GJ, Palmer JM, Walters MK, Nancarrow DJ, Parsons PG and Hayward NK. (1994). Int. J. Cancer, 58, 203-206.
68. Wang Y and Becker D. (1996). Oncogene, 12, 1069-1075.
69. Weinberg RA. (1995). Cancer Surveys, 25, 3-12.
70. Wiest JS, Franklin WA, Otstot JT, Forbey K, Varella-Garcia M, Rao K, Drabkin H, Gemmill R, Ahrent S, Sidransky D, Saccomanno G, Fountain JW and Anderson MW. (1997). Cancer Res., 57, 1-6.